ArticleTherapeutic advances in hematology2022

Circulating HMGB1 is increased in myelodysplastic syndrome but not in other bone marrow failure syndromes: proof-of-concept cross-sectional study.

Elia Apodaca-Chávez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.